Gut Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Type of Cancer
Breast Oncology

Phase

Division (Location)

Study ID

NCT#

Brief Description
Gut Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.